chrisvoncsefalvay/vaers-outcomes huggingface dataset:
elevated BP (180/105) and pulse (100); elevated BP (180/105) and pulse (100); My pulse was also irregular; I experienced pressure in my chest especially over my sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old non-pregnant female patient received first dose bnt162b2 (BNT162B2, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 24Feb2021 14:30 (Batch/Lot Number: EN6202) as SINGLE DOSE for covid-19 immunization at Hospital. Medical history included hypothyroidism, migraine and had allergies with niacin, codeine, Brazil nuts, onions. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. No other vaccine and no other medications in four weeks. She did not have covid prior vaccination. Patient did not test covid post vaccination. On 25Feb2021 21:30 (Thursday), after having the shot on Wednesday patient experienced pressure in her chest especially over her sternum, elevated BP (180/105) and pulse (100). Her pulse was normally about 48- 53 and BP 120/64 to 128/70. Her pulse was also irregular. She went to the emergency room (ER) where her electrocardiogram (EKG) was normal, and her pulse was about 74 and BP 170/100. She asked that it be checked again after waiting for an extended period without being seen. At that time, it 148/72. When she arrived home, we checked it again and it was 128/68 later coming down to 119/64. She never had an episode like that before. Patient did not received treatment for the events. The outcome of the events was recovered. No follow-up attempts are possible. No further information is expected.
day p/vax recv pt broke out w/pink whelp rash mainly to chest, back, legs;no fever, no dec activity;
dose 2 - mild rash with small red papules that developed 6 days after the injection. Was very itchy and uncomfortable. treated with benadryl PRN and slowly it went away within a week and a half.  dose 3 - 11 days after the dose, I noticed I was very itchy particularly on my underarms and back. I took a long acting antihistamine to try to go back to bed (the itching woke me up at midnight even though I initially noticed it around 10pm). The next day, my neck, legs, and arms were itchy, but i had a 6 hour drive and took another long acting antihistamine to get through my day. On the night of the 21st, my right foot was incredibly swollen and my legs were very itchy. I documented the rash with pictures on my phone, but the rash was on my arms, lets, lower back, and the tops of my feet. I took a benadryl and went to sleep. On the 22nd, I woke up at 2pm (I am typically up by 9am) and my face was so swollen that i was not able to put contacts in. The rash was all over my face, neck, chest, arms, palms of my hands, back, legs, and the tops and bottoms of my feet. I had another 6 hour drive ahead of my and was only able to take another long acting antihistamine. Anywhere i touched on my body instantly god red, swollen, hot, and itchy. Today is december 7th and still, anywhere i touch, within 60 seconds is swollen, red, hot, and itchy.   after the 6 hour drive on the 22nd, I started on prednisone after learning that that is the course of action taken by the infectious disease doctor at the hospital i work at. The steroid did not help. Neither did the long acting antihistamine. I have not been taking anything else (except my prescribed omeprazole).
Narrative:  5/3 patient spoke to PCP who instructed patient to continue  w/Hydrocortisone cream and could also try Loratadine as needed. Patient to follow up if gets worse, but per note was improving.
Received ZOSTAVAX 10-10-12 am. Noticed marked swelling Thursday. Reported swelling from armpit to elbow to dr office Friday. Dr ordered ice and BENADRYL 25 mg TID.
90 year homebound   black female with dementia received second shot of Pfizer vaccine one week after the first dose.  The first caregiver  present at the home  giver and sister gave information that this first shot and that she needed it. A second caregiver came to the house after the shot was given and said that she had a received a first at dose at Rush hospital a week before.  At the time of injection and 20 minutes thereafter , the patient reported no side effects.
Pt developed a large bruise at injection site and then proceded to develop a gradual onset of hives, small raised and pink and additionally developed a fine sandpaper rash.
This spontaneous report was received from a female patient of unknown age regarding herself. The patient's medical history and concurrent conditions were not provided. On an unknown date (reported as "a few years ago"), the patient was vaccinated with ZOSTAVAX injection (strength, dose, lot number, expiration date, route and anatomical location of administration were not reported), for prevention of shingles. On an unknown date, the patient developed "shingles on the right side of unspecified arm to her shoulder" (herpes zoster). The patient sought medical attention and went to the physician's office, but it was unknown if a treatment was given for the event. No product quality complaint was involved. The outcome of the herpes zoster and the causal relationship between the herpes zoster and ZOSTAVAX were unknown. Additional information has been requested.
102 oral fever (measured 1 hour after taking acetaminophen); severe chills; headache; injection site reaction (sore arm and redness).
Nausea, vomiting, disorientation, confusion, weakness, passing out. was taken to ER by ambulance, kept over night for observation, and released the next morning.
This is a spontaneous report from a contactable Pharmacist via Pfizer sales representative. A more than 70-year-old female patient of an unspecified age and ethnicity received PREVNAR 13 at single dose in the right arm and INFLUENZA VACCINE at an unspecified dose in the left arm, both via an unspecified route of administration on an unspecified date for immunisation. The patient medical history included dementia. Concomitant medications were not reported. On an unspecified date the patient experienced Prevnar 13 in the right arm, flu shot in the left arm with outcome of unknown, redness (about 3-4 inches in diameter) and swelling around the injection site with outcome of recovering, redness and swelling were experienced around the injection site with outcome of recovering. The redness and swelling was visible several days after vaccination but seemed to be improving with each day. It was unknown if the patient has shown similar reactions to other vaccines.
34-year-old woman with no significant past medical history presents with syncope event after receiving a COVID-19 vaccination prior to arrival. Patient describes lightheadedness and eventually falling forward. She did sustain facial abrasions to her forehead, bridge of the nose, and right zygomatic arch region. Complains of mild headache with without any nausea.
pt found saturday 4/23/22 at 410am unresponsive, CPR initiated, emergency responded, was unable to resuscitate patient
This spontaneous report as received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 24-JUL-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23, "10 Single dose 0.5mLVls 10SDV" and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 59.9 Fahrenheit (F) Degrees (15.5 Celsius) (highest recorded temperature) for a total of 3720 Hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Rash and swelling near injection shot about a week after receiving the shot. No rash or swelling initially.
Rapid heart rate; 1st dose 10Mar2021, 2nd dose 21Mar2021; 1st dose 10Mar2021, 2nd dose 21Mar2021; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER8732), intramuscular, administered in Arm Right on 21Mar2021 12:30 as single dose for COVID-19 immunization in a hospital. Medical history included, colonoscopy and polypectomy both on 08Jan2021. Family history of hypertension from an unknown date on the maternal side. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (lot number: EN6199) on 10Mar2021 1:15 pm for COVID-19 immunization and experienced insomnia and rapid heart rate that required hospital admission. On 31Mar2021 12:31, the patient experienced rapid heart rate. The patient was observed for 45 mins at site prior to release normal heart rate; cardiologist ordered heart monitoring for 2 day observation. The patient was treated with continuation of atenolol 75 mg. The reporter considered the event as non-serious. The patient received the first dose 10Mar2021, second dose 21Mar2021. The patient underwent lab tests and procedures which included echocardiogram: normal on 13Mar2021, electrocardiogram: 128 bpm fluctuated between normal to high on 12Mar2021, haemoglobin: 11.4 g/dl on 12Mar2021, heart rate: rapid on 31Mar2021, red blood cell count: 4.35 unit: M/Cmm on 12Mar2021, COVID-19 test: negative on 12Mar2021, and white blood cell count: 6.0 k/Cmm on 12Mar2021. The outcome of the event rapid heart rate was recovering.  No follow-up attempts are needed. No further information is expected.
Pt recvd vax & 2 days later, pt devel swelling of the hand & exp rt arm pain, paresthesia, numbness; sx lasted 2 wks, pt had residual joint pain in the rt thumb;
I've been experiencing intermittent sensations in my upper and lower chest [lung and heart] area since I received my 2nd Pfizer vaccination shot on June 22, 2021. It?s been happening for two weeks, today but I?m only now reporting it because I?m getting concerned. Each time it?s happened, it lasts for a couple of hours and it's scaring me.  I feel pressure in there like something?s not right. I?m not paranoid but I am concerned and want to report it.
Patient reports feeling pain in his upper right arm since shortly after being given the intramuscular shot of SHINGRIX. He received SHINGRIX in the right arm where he reports pain and FLUZONE QUADRIVALENT in the left arm intramuscularly but only feels pain in the right. At the time of the injection the arm that received SHINGRIX bleed more than the arm receiving FLUZONE which did not bleed at all. It is February 28th 2018 at the time this event is being reported. Patient reported taking tramadol which he has for back pain and his back pain was eased but his arm continued to ache. He is in more pain now than he was on the first day of the shot.
Redness, warmth, itching, pt. c/o bumps around site, tender to touch. Pt. noticed these on day after inject. 2/24/11 (Thursday).
My arm was a bit sore the evening after the shot but I expected that. Within 18 hours, I was feeling achy and sore all over. I didn't want to go out on Friday night but just stay in. It was only then that I looked at the injection site. I have a raised red welt approximately 3 inches in diameter. It has not subsided in the interim. I am now in day 4. I was achy again on the afternoon of the second day after injection. Yesterday, I was also lethargic.  I am not currently achy, but that has occurred in the afternoon not morning. My arm itches at the injection site, and is still somewhat painful. There is a lump on my arm.
devel 6cm local rxn around inj site;area red & warm doesn't seem painful to touch;
Mom states had a rash 3 days after vaccinations on 9/18/01. Today, per Mom, same rash on abdomen, tiny red dots. Gave dose of Benadryl with no change-child appeared fine. No fever at present time-97.9.
6 hrs after my pneumonia shot my right upper arm and neck became swollen. Sat. morning the fluid and swelling appeared in the lower part of right arm. I had constant pain where I was given the shot. After 2 doctor's visits I was given the proper emds and 2 1/2 wks later was okay.
I have come home from work and started with shortness of breath, tightness in the chest my heart was racing.
PATIENT RECEIVED SHINGRIX AND PREVNAR VACCINES IN PRIMARY CARE OFFICE ON 3/24/2023. PATIENT REPORTS NOTICING ARM PAIN ON 3.25.2023. ON 3.29.2023 PATIENT WAS SEEN AGAIN IN THE OFFICE WITH C/O RIGHT DELTOID PAIN, WARMTH, AND REDNESS. PATIENT WAS DIAGNOSED WITH CELLULITIS AND PRESCRIBED DOXYCYCLINE PO, PREDNISONE PO, AND TRIAMCINOLONE CREAM. ON 4/4/2023 WAS SEEN AGAIN IN THE OFFICE WITH PAINFUL BLISTERS IN HER MOUTH & ALONG THE TRIGEMINAL DERMATOME ON HER RIGHT SIDE, HEAD & BODY ACHES. SHE WAS STARTED ON ORAL ACYCLOVIR & CONTINUED ORAL PREDNISONE. ON 4/6/2023 SHE WAS SEEN AGAIN IN THE OFFICE & THE RASH WAS NOTED TOBE SPREAD/FAILING ORAL ACYCLOVIR. THE PATIENT WAS ADVISED TO PRESENT TO THE HOSPITAL EMERGENCY DEPARTMENT, WHERE SHE WAS ADMITTED ON 4/6/2023 FOR IV ANTIVIRAL THERAPY. SHE WAS TREATED WITH IV ACYCLOVIR, PREDNISONE EAR DROPS, TRIAMCINOLONE CREAM, AND CONTINUED ORAL PREDNISONE. HER LESIONS IMPROVED AND SHE WAS DISCHARGED HOME IN GOOD CONDITION ON 4/8/2023. SHE WAS SEEN AGAIN IN THE PCP OFFICE ON 4/13/2023 WHERE IT WAS NOTED HER LESIONS WERE HEALING. PATIENT CONTINUES TO ? HEADACHE AND RASH ITCHINESS ON 4/13/2023.
slight arm redness  at injection site with body aches  and lower back pain radiating to groin.
Right upper arm/deltoid area was red, hot to touch, very tender and swollen throughout. Treated as cellulitis with augmentin.
The patient was feeling sluggish and stated he just got a flu shot and an iron infusion; Initial information received on 13-Dec-2020 regarding an unsolicited valid non-serious case from consumer/ non-health care professional.  This case involved a 64-year-old male patient it was reported that the patient was feeling sluggish and stated he just got a flu shot and an iron infusion (sluggishness), while she received vaccines INFLUENZA VACCINE, TREPROSTINIL DIOLAMIN [ORENITRAM], TREPROSTINIL SODIUM [REMODULIN] and IRON.  Medical history, past medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing Pulmonary arterial hypertension.  Concomitant medications included TADALAFIL.   On an unknown date, the patient received INFLUENZA VACCINE [lot number: unknown and expiration date: unknown] at an unknown dose via unknown route in an unknown administration site for prophylactic vaccination.  On 12-Sep-2019, the patient received TREPROSTINIL DIOLAMIN [lot number: 2101646 and expiration date: 31-Jan-2019] at a dose of 0.125 mg via oral route in an unknown administration site for pulmonary arterial hypertension. On an unknown date dosage was changed to 0.25 mg then dosage was changed to 1.25 mg.  On an unknown date, the patient received TREPROSTINIL SODIUM [lot number: unknown and expiration date: unknown] at a dose of 0.013 ug/kg via subcutaneous route in an unknown administration site for pulmonary arterial hypertension.  On an unknown date, the patient received IRON [lot number: unknown and expiration date: unknown] at an unknown dose via unknown route in an unknown administration site for an unknown indication.  On an unknown date, (latency: unknown) it was reported that the patient was feeling sluggish and stated he just got a flu shot and an iron infusion (sluggishness) following the administration of suspect vaccine.  Details of laboratory data were not reported.   It was not reported if the patient received a corrective treatment.  Outcome of the event was not resolved.  There will be no information available regarding batch number in this case.
light headedness; felt detached; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 31Mar2021 at 10:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to sulfonamides (sulfa). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Concomitant medications included multi vitamins, fish oil (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 31Mar2021 at 10:45,  the patient experienced light headedness and feeling detached. It was reported that the patient waited in the pharmacy for more than 20 minutes after the vaccine, then left and got in the car. Patient  then experienced light headedness and  felt detached. So the patient sat in the car for another 20 minutes or so to see if it became worse. It did not get worse so the patient changed her plans, the patient was going to go food shopping and run some errands but did not because of the light headed feeling that she had experienced. The patient did not receive any treatment for the reported events. The clinical outcome of the events of  light headedness and feeling detached was recovered on 31Mar2021.  No follow-up attempts are needed. No further information is expected.
12 hours after shot, all over body aches, sore arm and shoulder, fever.  Shortly after, a headache occurred. The symptoms lasted all day and were mostly gone except for a small headache and fuzzy brain after 30 hours. All clear after about 36 hours.
Patient with history of type II diabetes. She was brought to the ED by EMS on 4/9/23 for evaluation of weakness that began that day. Notably, she is on 2L O2 at baseline. She did not use any supplemental oxygen that day and felt more short of breath. A rapid COVID PCR test resulted positive. Ultimately the patient was admitted 4/9/23 - 4/14/23 with discharge diagnoses including acute on chronic respiratory failure with hypoxia and hypercarbia and COVID-19. During admission, she briefly required BiPAP support and was started on a 10 day course of Decardron. Of note, she has received the primary COVID vaccine and one booster.
Tinnitus; This is a spontaneous report from a non-contactable consumer, the patient.  A 61-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an Intramuscular route of administration on 27Mar2021 as a single dose for COVID-19 immunisation. Medical history included cancer-multiple myeloma. The patient received unspecified medication within two weeks of vaccination.  It was unknown, whether the patient had allergic to medications, food, or other products Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced tinnitus after receiving second shot of Pfizer vaccine. Tinnitus was loud and lasted for about 4 hours. On an unknown date in 2021, the patient underwent unknown COVID-19 test and result was unknown. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tinnitus was recovered on an unknown date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After my vaccination, I felt fine. I tested positive for COVID-19 in October. After contracting COVID-19, my body hasn't been the same. Something is lingering. I haven't felt 100% since then. I've been experiencing brain fog, exhaustion, uneasiness about breathing, and uneasiness about the heart. I tested positive for COVID-19 for about three weeks. The symptoms were mild, but they lingered. When I came back from a trip, I also contracted bronchitis that was on the verge of pneumonia. They gave me a Z-PAK, prednisone, and benzonatate. I had a reaction that felt like my throat was closing and had to call 911. By the time the first responders got to me, I felt better. I did not go to the hospital at that time. A couple of days later, I had heart palpations. I went to the emergency room. They monitored me for 12 hours, but they did not give me medication. I've also had diarrhea.
-Onset after 1 hour - light-sensitivity migraine. Children's dose aspirin taken and decreased in severity at 37 hours. -Onset after 4 hours - altered temperature, between 95.9 F - 97.1 F (average is 98.2 F). Ongoing symptom after 96 hours (97.1 F as of typing this, taken on the hour). -Onset after 6 hours - feeling of physical exhaustion without sleepiness. Decreased in severity at 70 hours. -Onset after 18 hours - bone and joint pain, focused in mid-back, shoulders, hips, knees, and ankles. Decreased in severity at 42 hours. -Onset after 21 hours - Decreased mobility in shoulders, hips, and ankles. Decreased in severity at 38 hours.
Skin on fingertips rubbing off.  Not to the point of fingers actually bleeding.  Ongoing.  Don't know what brand of flu shot she received about a week after the booster (third) shot.  I just picked one.  Again, we were travelling and just stopped at a pharmany.
I had joint pain and stiffness in lower part of the body also left calves feeling like pins and needles.
Headache on day 1 evening and all day 2  Day 5-7 tenderness on left side of face in distribution of trigeminal nerve. like trigeminal neuralgia. Gone by day 7 after vaccine. It only occurred on the left side (same side as left upper arm vaccination)
Received Moderna Covid-19 vaccine monovalent instead of the bivalent dose for their booster dose.; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Received Moderna Covid-19 vaccine monovalent instead of the bivalent dose for their booster dose.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Received Moderna Covid-19 vaccine monovalent instead of the bivalent dose for their booster dose.) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Received Moderna Covid-19 vaccine monovalent instead of the bivalent dose for their booster dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Received Moderna Covid-19 vaccine monovalent instead of the bivalent dose for their booster dose.).    Concomitant Medication use information was not provided by reporter. During a Moderna Covid-19 vaccine clinic Patient received Moderna Covid-19 vaccine monovalent instead of the bivalent dose for their booster dose. The Nurse stated that this was happened because the monovalent vaccine with the purple border was labeled booster doses. Treatment Medication use information was not provided by reporter.